多次垂体卒中-海绵窦侵犯是再出血的主要危险因素
维也纳医科大学1990至2017年收治76例临床有症状的垂体卒中手术患者,其中4例(5.3%)术后发生多次垂体卒中。多次卒中者术前Knosp分级更高(中位4级)、术中海绵窦侵犯更常见(P=0.01),且均残留腺瘤;海绵窦内残留肿瘤者再发卒中率为23.5%。作者建议对海绵窦内残留肿瘤早期治疗以减少再发卒中风险。
要点
- 多次垂体卒中患者术前Knosp分级中位4级,术中海绵窦侵犯更常见(P=0.01)。
- 海绵窦内残留肿瘤患者再发卒中率为23.5%,多次卒中者均残留腺瘤。
- 多次卒中者眼肌麻痹率75% vs 单次14.1%(P=0.01),均需长期激素替代。
核心结论
- 海绵窦侵犯和次全切除是垂体腺瘤多次卒中的高危因素。
- 作者建议对海绵窦内残留肿瘤早期治疗,以尽量减少再发卒中及其后续更差临床结局的风险。
研究设计与样本
- 维也纳医科大学回顾性研究,纳入1990至2017年因临床有症状垂体卒中手术治疗的76例患者。
- 其中4例(5.3%)在初次手术后发生多次垂体卒中,复习神经影像、临床资料和术中所见分析多次卒中的潜在危险因素。
主要发现
- 多次卒中患者术前影像Knosp分级显著更高(中位4级),术中海绵窦侵犯更常见(P=0.01)。
- 所有多次垂体卒中病例术后均残留腺瘤。
- 海绵窦内残留肿瘤患者再发卒中率为23.5%。
- 单次卒中患者肿瘤复发/残留切除时间(中位2.2年)显著早于多次卒中患者(中位5.4年;P=0.05)。
- 多次垂体卒中导致眼肌麻痹率显著更高(75% vs 14.1%;P=0.01),且所有病例均需长期激素替代治疗。
临床怎么用
- 作者建议对海绵窦内残留肿瘤早期治疗,以尽量减少再发卒中及后续更差临床结局的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pituitary apoplexy is a rare but potentially life-threatening disorder that occurs in up to 10% of adenomas. Whereas risk factors for the initial hemorrhagic event are well described, there is minor knowledge on clinical symptomatic recurrent pituitary apoplexies. METHODS: At the Medical University of Vienna, 76 patients were surgically treated for clinical symptomatic pituitary apoplexy between 1990 and 2017. Four patients (5.3%) suffered multiple pituitary apoplexies after initial surgery. In this retrospective study, neuroradiologic images, clinical data, and intraoperative findings were reviewed for potential risk factors of multiple apoplexies in pituitary adenomas. RESULTS: Patients with multiple apoplexies had significantly higher Knosp grading on preoperative imaging (median grade 4), and more frequently observed cavernous sinus invasion intraoperatively (P = 0.01). Consequently, all cases with multiple pituitary apoplexies remained with residual adenoma postoperatively. In cases of residual tumor within the cavernous sinus, recurrent apoplexy occurred in 23.5% of patients. A tumor recurrence/residual was resected significantly earlier in patients with single apoplexy (median 2.2 years) than in patients with multiple apoplexies (median 5.4 years; P = 0.05). Multiple pituitary apoplexies caused significantly greater rates of ophthalmoplegia (75% vs. 14.1%; P = 0.01) and long-term hormone-replacement therapy was necessary in all cases. CONCLUSIONS: Cavernous sinus invasion and subtotal resection are high risk factors for multiple apoplexies in pituitary adenomas. Early treatment is recommended for residual tumor in the cavernous sinus to minimize the risk of recurrent apoplexy with subsequent worse clinical outcome.
引用
- Hosmann A, Micko A, Frischer JM, et al. Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage. World Neurosurg. 2019. PMID: 30851467. doi:10.1016/j.wneu.2019.02.138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。